首页
期刊简介
编 委 会
期刊订阅
百年学会 医星璀璨
名院风范
学科风华
菁英风采
投稿须知
过刊浏览
联系我们
篇名
关键词
作者
作者单位
摘要
关键词
注册本刊作者
作者投稿查稿
专家远程审稿
编辑在线审稿
编务办公专区
主编办公专区
下载文档
《上海医学》审稿费代缴委托书
《上海医学》杂志2024年征订启事
《上海医学》期刊编审系统审稿专家使用手册
工作动态
03-05
《上海医学》杂志2024年度“春蕾杯”论文评比征文通知
06-14
创新驱动,培育人才—《上海医学》2021年度春蕾计划评审结果揭晓
01-21
《上海医学》期刊影响力指标和学科排名取得显著提升
01-20
《上海医学》恭祝大家新年快乐!
08-18
作废声明
联系方式
发行周期:
月刊
主管单位:
上海市卫生健康委员会
主办单位:
上海市医学会
编辑出版:
《上海医学》编辑部
联系地址:
上海市北京西路1623号
邮编:
200040
电话:
021-62178606
传真:
021-62178606
邮箱:
smasmj@shsma.org.cn
ISSN:
ISSN0253-9934
CN:
CN31-1366/R
收款账号:
1001255309008900719
账户名:
上海市医学会
开户行:
工商银行上海市静安寺支行
友情链接
上海市医学会
当前位置:首页 >
过刊浏览
->
2011年第6期
Ghrelin在缺血预处理抗大鼠海马神经元缺血再灌损伤中的作用
The role of ghrelin in the protection of ischemic preconditioning against ischemia/reperfusion injury in rat hippocampal neurons
浏览(2435) 下载(0)
DOI:
作者:
刘亚君,陈筱南,刘克敬,陈连璧
LIU Yajun, CHEN Xiaonan, LIU Kejing, CHEN Lianbi
作者单位:
中国医学科学院微循环研究所,北京100005;山东省医学科学院附院,济南250013;山东大学医学院, 济南250012;
Institute of Microcirculation, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005; Affiliated Hospital, Shandong Academy of Medical Sciences, Jinan 250013; Institute of Physiology, School of Medicine, Shandong University, Jinan 250012,China
关键词:
缺血预处理;缺血再灌注损伤;海马;神经元;Ghrelin;UCP2
Ischemic preconditioning; Ischemia/reperfusion injury; Hippocampus; Neurons; Ghrelin; UCP2
摘要:
目的:探讨ghrelin在脑缺血预处理(ischemic preconditioning, IPC)保护海马神经元缺血再灌注损伤中的作用及其与线粒体解偶联蛋白-2(uncoupling protein 2, UCP2)表达的关系。 方法:用四血管阻断法(4 VO)建立全脑缺血模型,将大鼠随机分为对照组(CON组)、缺血再灌组(I/R组)、缺血预处理+缺血再灌组(IPC+I/R组)、缺血再灌+生理盐水组(I/R+N组)、缺血再灌+ghrelin组(I/R+G组)和对照+生理盐水组(CON+N组)。用ELISA法检测缺血再灌注后血清中ghrelin水平;大鼠注射ghrelin后,HE染色观察海马CA1区神经元的组织形态学变化,免疫组化测定海马CA1区Bcl-2表达,RT-PCR法检测海马UCP2 mRNA表达。 结果:ELISA法检测结果显示,致死性缺血再灌24 h后,IPC+I/R组血浆ghrelin 浓度较对照组和I/R组明显升高(p<0.001),并且持续72 h(p<0.001)。I/R组与对照组各对应时间点ghrelin 水平均无显著变化。HE染色结果显示,注射ghrelin后,CON+N组、I/R+N组和I/R+G组存活细胞数分别为251.3 ± 8.7、28.5±7.3和179.3±11.5/mm,I/R+G组存活神经元数目明显多于I/R+N组(p<0.001),但明显少于对照组(p<0.001)。免疫组化结果显示,CON+N组、I/R+N组和I/R+G组大鼠海马CA1区神经元Bcl-2蛋白表达均不明显;RT-PCR结果显示,I/R+G组海马CA1区有大量UCP2 mRNA表达,明显多于CON+N组和I/R+N组(p< 0.001)。 结论:缺血预处理能促进ghrelin释放,并通过ghrelin上调海马CA1区神经元UCP2的表达,减轻缺血再灌注损伤。
AIM: To explore the role and mechanism of ghrelin in the neuroprotection of IPC against ischemia/reperfusion injury of hippocampal neurons and the relationship between ghrelin and UCP2. METHODS: A rat 4-vessel global ischemia model was used. Rats were divided into control group (CON group), ischemia/ reperfusion group (I/R group), ischemic preconditioning+ischemia/reperfusion group (IPC+I/R group), ischemia/ reperfusion+ghrelin group (I/R+G group), ischemia/ reperfusion+saline group (I/R+N group) and control+saline group (CON+N group). The ghrelin levels in serum at 24 h, 48 h and 72 h after ischemia/reperfusion were measured by ELISA. The morphological changes of neurons in hippocampal CA1 region were examined by HE staining. The expression of Bcl-2 of the neurons in the same region was detected by immunohistochemistry and the expression of UCP2 mRNA of hippocampal neurons was assayed by RT-PCR. RESULTS: At 24 h after lethal ischemia, the ghrelin level in serum in IPC+I/R group was increased and significantly higher than that in CON group and I/R group (p<0.001). The high level continued to 72 h after lethal ischemia (p<0.001). In I/R group, the ghrelin level in serum was constant, and not significantly different compared with the CON group. After administration of ghrelin, the numbers of surviving neurons in the CON+N group, I/R+N group and I/R+G group were 251.3±8.7, 28.5±7.3 and 179.3±11.5/mm respectively. The number of surviving neurons in I/R+G group was greater than that in I/R+N group (p<0.001) and less than that in CON+N group (p<0.001). The expression of Bcl-2 in the neurons of hippocampal CA1 region in CON+N group, I/R+N group and I/R+G group was not obvious. RT-PCR showed a signignificantly stronger expression of UCP2 mRNA in I/R+G group than in CON+N group and I/R+N group (p<0.001). CONCLUSION: Ischemia preconditioning may promote the release of ghrelin, which may upregulate the expression of UCP2 in the neurons of the hippcampal CA1 region and alleviate the ischemia/reperfution injury.